Type III IFN receptor expression and functional characterisation in the pteropid bat, Pteropus alecto

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Zhou, Peng ^a,b   Cowled, Chris ^a   Marsh, Glenn A ^a   Shi, Zhengli ^b   Wang, Lin Fa ^a,c   Baker, Michelle L ^a,d  

^a CSIRO   (Australia)

^b WUHAN INSTITUTE OF VIROLOGY   (China)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON RECEPTOR; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 28; INTERLEUKIN 29; INTERFERON;

ANIMAL CELL; ARTICLE; BAT; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EPITHELIUM CELL; GENE; IFNLAMBDAR1 GENE; IL10R2 GENE; IMMUNOCOMPETENT CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEQUENCE ALIGNMENT; SPECIES DIFFERENCE; TISSUE DISTRIBUTION; AMINO ACID SEQUENCE; ANIMAL; CELL LINE; CHEMISTRY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MOLECULAR CLONING; MOLECULAR GENETICS; MOUSE; PROTEIN TRANSPORT;

MAMMALIA; PTEROPUS ALECTO;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CHIROPTERA; CLONING, MOLECULAR; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; INTERFERONS; MICE; MOLECULAR SEQUENCE DATA; PROTEIN TRANSPORT; RECEPTORS, INTERFERON; RECEPTORS, INTERLEUKIN-10; TRANSCRIPTION, GENETIC;

EID: 80053185391     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025385     Document Type: Article

References (25)

1. Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, et al. (2003) IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 4: 69-77.
2. Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, et al. (2003) IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 4: 63-8.
3. Langer JA, Cutrone EC, Kotenko S, (2004) The Class II cytokine receptor (CRF2) family: overview and patterns of receptor-ligand interactions. Cytokine and Growth Factor Reviews 15: 33-48.
4. Ank N, Paludan SR, (2009) Type III IFNs: new layers of complexity in innate antiviral immunity. Biofactors 35: 82-7.
5. Witte K, Witte E, Sabat R, Wolk K, (2010) IL-28A, IL-28B, and IL-29: Promising cytokines with type I interferon-like properties. Cytokine Growth Factor Rev 21: 237-251.
6. Sheikh F, Baurin VV, Lewis-Antes A, Shah NK, Smirnov SV, et al. (2004) Cutting edge: IL-26 signals through a novel receptor complex composed of IL-20 receptor 1 and IL-10 receptor 2. J Immunol 172: 2006-10.
7. Li J, Tomkinson KN, Tan XY, Wu P, Yan G, et al. (2004) Temporal associations between interleukin 22 and the extracellular domains of IL-22R and IL-10R2. Int Immunopharmacol 4: 693-708.
8. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A, (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19: 683-765.
9. Wolk K, Sabat R, (2006) Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells. Cytokine Growth Factor Rev 17: 367-80.
10. Qi Z, Nie P, Secombes CJ, Zou J, (2010) Intron-containing type I and type III IFN coexist in amphibians: refuting the concept that a retroposition event gave rise to type I IFNs. J Immunol 184: 5038-46.
11. Lasfar A, Lewis-Antes A, Smirnov SV, Anantha S, Abushahba W, et al. (2006) Characterization of the mouse IFN-lambda ligand-receptor system: IFN-lambdas exhibit antitumor activity against B16 melanoma. Cancer Res 66: 4468-77.
12. Witte K, Gruetz G, Volk HD, Looman AC, Asadullah K, et al. (2009) Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines. Genes Immun 10: 702-14.
13. Sommereyns C, Paul S, Staeheli P, Michiels T, (2008) IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog 4: e1000017.
14. Donnelly RP, Sheikh F, Kotenko SV, Dickensheets H, (2004) The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain. J Leukoc Biol 76: 314-21.
15. Pestka S, Krause CD, Walter MR, (2004) Interferons, interferon-like cytokines, and their receptors. Immunol Rev 202: 8-32.
16. Ank N, Iversen MB, Bartholdy C, Staeheli P, Hartmann R, et al. (2008) An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity. J Immunol 180: 2474-85.
17. Calisher CH, Childs JE, Field HE, Holmes KV, Schountz T, (2006) Bats: important reservoir hosts of emerging viruses. Clin Microbiol Rev 19: 531-45.
18. Crameri G, Todd S, Grimley S, McEachern JA, Marsh GA, et al. (2009) Establishment, immortalisation and characterisation of pteropid bat cell lines. PLoS One 4: e8266.
19. Baker ML, Tachedjian M, Wang LF, (2010) Immunoglobulin heavy chain diversity in Pteropid bats: evidence for a diverse and highly specific antigen binding repertoire. Immunogenetics 62: 173-84.
20. Cowled C, Baker M, Tachedjian M, Zhou P, Bulach D, et al. (2011) Molecular characterisation of Toll-like receptors in the black flying fox Pteropus alecto. Dev Comp Immunol 35: 7-18.
21. Zhou P, Cowled C, Todd S, Crameri G, Virtue ER, et al. (2011) Type III IFNs in pteropid bats: differential expression patterns provide evidence for distinct roles in antiviral immunity. J Immunol 186: 3138-47.
22. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ, (1990) Basic local alignment search tool. J Mol Biol 215: 403-10.
23. Thompson JD, Higgins DG, Gibson TJ, (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22: 4673-80.
24. Dumoutier L, Tounsi A, Michiels T, Sommereyns C, Kotenko SV, et al. (2004) Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: similarities with type I interferon signaling. J Biol Chem 279: 32269-74.
25. Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, et al. (2004) IL-22 increases the innate immunity of tissues. Immunity 21: 241-54.